4.5 Article

Neutrophil extracellular traps activate IL-8 and IL-1 expression in human bronchial epithelia

Publisher

AMER PHYSIOLOGICAL SOC
DOI: 10.1152/ajplung.00144.2019

Keywords

airway inflammation; IL-1; IL-8; IL-36; neutrophil extracellular trap

Funding

  1. National Heart, Lung, and Blood Institute [1K08HL124191]
  2. Cystic Fibrosis Foundation [HUDOCK15I0]
  3. Parker B. Francis fellowship
  4. University of Cincinnati Clinical and Translational Science Award CT2 Scholar Award [KL2TR001426]
  5. University of Cincinnati
  6. Cincinnati Children's Hospital Medical Center

Ask authors/readers for more resources

Neutrophil extracellular traps (NETs) provide host defense but can contribute to the pathobiology of diverse human diseases. We sought to determine the extent and mechanism by which NETs contribute to human airway cell inflammation. Primary normal human bronchial epithelial cells (HBEs) grown at air-liquid interface and wild-type (wt)CFBE41o- cells (expressing wtCFTR) were exposed to cell-free NETs from unrelated healthy volunteers for 18 h in vitro. Cytokines were measured in the apical supernatant by Luminex, and the effect on the HBE transcriptome was assessed by RNA sequencing. NETs consistently stimulated IL-8, TNF-alpha, and IL-1 alpha secretion by HBEs from multiple donors, with variable effects on other cytokines (IL-6. G-CSF, and GM-CSF). Expression of HBE RNAs encoding IL-1 family cytokines, particularly IL-36 subfamily members, was increased in response to NETs. NET exposure in the presence of anakinra [recombinant human IL -1 receptor antagonist (rhIL-1RA)] dampened NET-induced changes in IL-8 and TNF-alpha proteins as well as IL-36 alpha RNA. rhIL-36RA limited the increase in expression of proinflammatory cytokine RNAs in HBEs exposed to NETs. NETs selectively upregulate an IL-1 family cytokine response in HBEs, which enhances IL-8 production and is limited by rhIL-1RA. The present findings describe a unique mechanism by which NETs may contribute to inflammation in human lung disease in vivo. NET-driven IL-1 signaling may represent a novel target for modulating inflammation in diseases characterized by a substantial NET burden.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available